UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cognitive impact of COVID-19: looking beyond the short term

Alzheimer's research & therapy, 2020-12, Vol.12 (1), p.170-170, Article 170

2020

Volltextzugriff (PDF)

Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease

PloS one, 2015-03, Vol.10 (3), p.e0119452-e0119452

2015

Volltextzugriff (PDF)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study

International journal of epidemiology, 2020-08, Vol.49 (4), p.1132-1140

2020

Volltextzugriff (PDF)

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Acta neuropathologica, 2020-03, Vol.139 (3), p.485-502

2020

Volltextzugriff (PDF)

Small RNA modifications in Alzheimer's disease

Neurobiology of disease, 2020-11, Vol.145, p.105058-105058, Article 105058

2020

Volltextzugriff (PDF)

Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease?

Lancet neurology, 2007-04, Vol.6 (4), p.373-378

2007

Volltextzugriff (PDF)

Alzheimer's disease–like pathology has transient effects on the brain and blood metabolome

Neurobiology of aging, 2016-02, Vol.38, p.151-163

2016

Volltextzugriff (PDF)

Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia

Brain (London, England : 1878), 2014-05, Vol.137 (5), p.1524-1532

2014

Volltextzugriff (PDF)

CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease

PloS one, 2012-11, Vol.7 (11), p.e48225-e48225

2012

Volltextzugriff (PDF)

Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease

Metabolites, 2017-06, Vol.7 (2), p.28

2017

Volltextzugriff (PDF)

Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism

Cells (Basel, Switzerland), 2021-09, Vol.10 (10), p.2591

2021

Volltextzugriff (PDF)

BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging

PloS one, 2013-10, Vol.8 (10), p.e78806

2013

Volltextzugriff (PDF)

Distribution and Expression of Picalm in Alzheimer Disease

Journal of neuropathology and experimental neurology, 2010-10, Vol.69 (10), p.1071-1077

2010

Volltextzugriff (PDF)

Angiotensins in Alzheimer's disease – friend or foe?

Trends in neurosciences (Regular ed.), 2009-12, Vol.32 (12), p.619-628

2009

Volltextzugriff (PDF)

Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease

American journal of epidemiology, 2005-08, Vol.162 (4), p.305-317

2005

Volltextzugriff (PDF)

Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage

PloS one, 2013-04, Vol.8 (4), p.e59554-e59554

2013

Volltextzugriff (PDF)

What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

Alzheimer's research & therapy, 2018-05, Vol.10 (1), p.51-51, Article 51

2018

Volltextzugriff (PDF)

LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: Relationship to cerebral amyloid angiopathy and APOE status

Neuroscience letters, 2012-09, Vol.525 (2), p.123-128

2012

Volltextzugriff (PDF)

Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier

Chemical reviews, 2013-03, Vol.113 (3), p.1877-1903

2013

Volltextzugriff (PDF)

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment

Brain (London, England : 1878), 2016-11, Vol.139 (11), p.2957-2969

2016

Volltextzugriff (PDF)

Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors

Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12202-n/a

2021

Volltextzugriff (PDF)

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease

Acta neuropathologica communications, 2019-04, Vol.7 (1), p.57-57, Article 57

2019

Volltextzugriff (PDF)

Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project

Neurobiology of aging, 2012, Vol.33 (1), p.202.e1-202.e13

2012

Volltextzugriff (PDF)

Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

Expert opinion on investigational drugs, 2013-10, Vol.22 (10), p.1229-1242

2013

Volltextzugriff (PDF)

Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential

Communications biology, 2022-11, Vol.5 (1), p.1279-11, Article 1279

2022

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(236)
Reviews
(2)
Texte
(2)
Buchkapitel
(1)

Sprache

Englisch
(241)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cognitive impact of COVID-19: looking beyond the short term

Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Small RNA modifications in Alzheimer's disease

Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease?

Alzheimer's disease–like pathology has transient effects on the brain and blood metabolome

Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia

CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease

Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease

Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism

BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging

Distribution and Expression of Picalm in Alzheimer Disease

Angiotensins in Alzheimer's disease – friend or foe?

Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease

Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage

What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: Relationship to cerebral amyloid angiopathy and APOE status

Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment

Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease

Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project

Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential

Suchergebnisse filtern